List of Tables
Table 1. Global Gene Cell Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immune Cells
Table 3. Key Players of Stem Cell
Table 4. Key Players of Viral Vector
Table 5. Key Players of Plasmid DNA
Table 6. Global Gene Cell Therapy CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Gene Cell Therapy CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Gene Cell Therapy CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Gene Cell Therapy CDMO Market Share by Region (2019-2024)
Table 10. Global Gene Cell Therapy CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Gene Cell Therapy CDMO Market Share by Region (2025-2030)
Table 12. Gene Cell Therapy CDMO Market Trends
Table 13. Gene Cell Therapy CDMO Market Drivers
Table 14. Gene Cell Therapy CDMO Market Challenges
Table 15. Gene Cell Therapy CDMO Market Restraints
Table 16. Global Gene Cell Therapy CDMO Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Gene Cell Therapy CDMO Market Share by Players (2019-2024)
Table 18. Global Top Gene Cell Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Cell Therapy CDMO as of 2023)
Table 19. Ranking of Global Top Gene Cell Therapy CDMO Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Gene Cell Therapy CDMO Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Gene Cell Therapy CDMO, Headquarters and Area Served
Table 22. Global Key Players of Gene Cell Therapy CDMO, Product and Application
Table 23. Global Key Players of Gene Cell Therapy CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gene Cell Therapy CDMO Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Gene Cell Therapy CDMO Revenue Market Share by Type (2019-2024)
Table 27. Global Gene Cell Therapy CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Gene Cell Therapy CDMO Revenue Market Share by Type (2025-2030)
Table 29. Global Gene Cell Therapy CDMO Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Gene Cell Therapy CDMO Revenue Market Share by Application (2019-2024)
Table 31. Global Gene Cell Therapy CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Gene Cell Therapy CDMO Revenue Market Share by Application (2025-2030)
Table 33. North America Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Gene Cell Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Gene Cell Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Gene Cell Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Gene Cell Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Gene Cell Therapy CDMO Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Gene Cell Therapy CDMO Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Gene Cell Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Gene Cell Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Gene Cell Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Gene Cell Therapy CDMO Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Gene Cell Therapy CDMO Market Size by Country (2025-2030) & (US$ Million)
Table 48. Catalent Company Details
Table 49. Catalent Business Overview
Table 50. Catalent Gene Cell Therapy CDMO Product
Table 51. Catalent Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 52. Catalent Recent Development
Table 53. Lonza Company Details
Table 54. Lonza Business Overview
Table 55. Lonza Gene Cell Therapy CDMO Product
Table 56. Lonza Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 57. Lonza Recent Development
Table 58. Thermo Fisher Company Details
Table 59. Thermo Fisher Business Overview
Table 60. Thermo Fisher Gene Cell Therapy CDMO Product
Table 61. Thermo Fisher Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 62. Thermo Fisher Recent Development
Table 63. ACG Biologics Company Details
Table 64. ACG Biologics Business Overview
Table 65. ACG Biologics Gene Cell Therapy CDMO Product
Table 66. ACG Biologics Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 67. ACG Biologics Recent Development
Table 68. Charles River Company Details
Table 69. Charles River Business Overview
Table 70. Charles River Gene Cell Therapy CDMO Product
Table 71. Charles River Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 72. Charles River Recent Development
Table 73. Oxford Biomedica Company Details
Table 74. Oxford Biomedica Business Overview
Table 75. Oxford Biomedica Gene Cell Therapy CDMO Product
Table 76. Oxford Biomedica Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 77. Oxford Biomedica Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Gene Cell Therapy CDMO Product
Table 81. Novartis Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. OBiO Company Details
Table 84. OBiO Business Overview
Table 85. OBiO Gene Cell Therapy CDMO Product
Table 86. OBiO Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 87. OBiO Recent Development
Table 88. GenScript Company Details
Table 89. GenScript Business Overview
Table 90. GenScript Gene Cell Therapy CDMO Product
Table 91. GenScript Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 92. GenScript Recent Development
Table 93. Pharmaron Company Details
Table 94. Pharmaron Business Overview
Table 95. Pharmaron Gene Cell Therapy CDMO Product
Table 96. Pharmaron Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 97. Pharmaron Recent Development
Table 98. Porton Company Details
Table 99. Porton Business Overview
Table 100. Porton Gene Cell Therapy CDMO Product
Table 101. Porton Revenue in Gene Cell Therapy CDMO Business (2019-2024) & (US$ Million)
Table 102. Porton Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Gene Cell Therapy CDMO Picture
Figure 2. Global Gene Cell Therapy CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Gene Cell Therapy CDMO Market Share by Type: 2023 VS 2030
Figure 4. Immune Cells Features
Figure 5. Stem Cell Features
Figure 6. Viral Vector Features
Figure 7. Plasmid DNA Features
Figure 8. Global Gene Cell Therapy CDMO Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Gene Cell Therapy CDMO Market Share by Application: 2023 VS 2030
Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
Figure 11. Research and Academic Institutions Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. Gene Cell Therapy CDMO Report Years Considered
Figure 15. Global Gene Cell Therapy CDMO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Gene Cell Therapy CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Gene Cell Therapy CDMO Market Share by Region: 2023 VS 2030
Figure 18. Global Gene Cell Therapy CDMO Market Share by Players in 2023
Figure 19. Global Top Gene Cell Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Cell Therapy CDMO as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Gene Cell Therapy CDMO Revenue in 2023
Figure 21. North America Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Gene Cell Therapy CDMO Market Share by Country (2019-2030)
Figure 23. United States Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Gene Cell Therapy CDMO Market Share by Country (2019-2030)
Figure 27. Germany Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Gene Cell Therapy CDMO Market Share by Region (2019-2030)
Figure 35. China Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Gene Cell Therapy CDMO Market Share by Country (2019-2030)
Figure 43. Mexico Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Gene Cell Therapy CDMO Market Share by Country (2019-2030)
Figure 47. Turkey Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Gene Cell Therapy CDMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Catalent Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 51. Lonza Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 52. Thermo Fisher Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 53. ACG Biologics Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 54. Charles River Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 55. Oxford Biomedica Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 56. Novartis Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 57. OBiO Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 58. GenScript Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 59. Pharmaron Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 60. Porton Revenue Growth Rate in Gene Cell Therapy CDMO Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
